Department of Clinical Biochemistry and Pharmacology, The Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel.; The Energy and Resources Institute, India Habitat Centre, Lodi Road, New Delhi 110003, India.
Department of Clinical Biochemistry and Pharmacology, The Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O. Box 653, Beer Sheva 84105, Israel..
J Control Release. 2017 Jul 10;257:32-39. doi: 10.1016/j.jconrel.2016.12.031. Epub 2016 Dec 29.
Targeted delivery to the cell nucleus can enhance the efficiency of drugs with nuclear site of action (some anti-cancer agents, DNA drugs, etc.), and can reduce their toxicity. Such targeting can be attained using nano-drug delivery systems (nano-DDSs) decorated with nuclear targeting sequences (such as nuclear localization sequence peptides, NLS). Several types of nano-DDSs decorated with NLS peptides were designed, but their investigation usually did not include quantitate analysis of the decoration efficiency and its correlation with the nano-DDSs intracellular localization. Thus, the major mechanisms and limiting factors of the nano-DDSs nuclear targeting are largely unknown yet. In this study, we report quantitative data for specific nano-formulation (CdSe-ZnS quantum dots) that include the efficiencies of its decoration with NLS residues and of its nuclear and perinuclear targeting, and demonstrate correlation between these parameters. For instance, QDs decorated with 83, 246, and 265 NLS peptides accumulated efficiently in the nucleus of HeLa cells or its vicinity (an average of 30.4%, 43.3%, and 49.0% of the intracellular QDs, respectively). On the other hand, QDs decorated with 63, 231, and 308 scrambled peptides accumulated in the nucleus of HeLa cells or its vicinity to a much lower extent (an average of 17.3%, 21.1%, and 25.5% of the intracellular QDs, respectively). Thus, results of our study provide important insights into the structure-activity correlations (i.e., the relationships between the formulation properties and the intracellular fate of nano-DDSs) of nuclear-targeted drug delivery. We plan to apply the research tools that were developed in the course of this and our previous studies to investigate the nuclear and perinuclear targeting activities of different NLS sequences, and to investigate the effects of nano-DDSs size, charge, shape, decoration efficiency with nuclear targeting sequences, and other structural factors on nuclear and perinuclear targeting efficiency.
靶向细胞核可以提高具有核作用部位的药物(如一些抗癌药物、DNA 药物等)的效率,并降低其毒性。这种靶向作用可以通过用核靶向序列(如核定位序列肽,NLS)修饰的纳米药物传递系统(nano-DDS)来实现。已经设计了几种用 NLS 肽修饰的 nano-DDS,但它们的研究通常不包括对修饰效率及其与 nano-DDS 细胞内定位的相关性进行定量分析。因此,nano-DDS 核靶向的主要机制和限制因素在很大程度上仍然未知。在这项研究中,我们报告了特定纳米制剂(CdSe-ZnS 量子点)的定量数据,包括其用 NLS 残基修饰的效率及其核和核周靶向的效率,并证明了这些参数之间的相关性。例如,用 83、246 和 265 个 NLS 肽修饰的 QD 能够有效地在 HeLa 细胞的细胞核或其附近积累(分别为细胞内 QD 的 30.4%、43.3%和 49.0%)。另一方面,用 63、231 和 308 个乱序肽修饰的 QD 在 HeLa 细胞的细胞核或其附近积累的程度要低得多(分别为细胞内 QD 的 17.3%、21.1%和 25.5%)。因此,我们的研究结果为核靶向药物传递的结构-活性相关性(即制剂特性与纳米 DDSs 细胞内命运之间的关系)提供了重要的见解。我们计划将在本研究和以前的研究中开发的研究工具应用于研究不同 NLS 序列的核和核周靶向活性,并研究 nano-DDSs 的大小、电荷、形状、核靶向序列的修饰效率以及其他结构因素对核和核周靶向效率的影响。